These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19365391)

  • 1. [MRI-parameters of frontal lobes in schizophrenia: correlations with the level of autoantibodies to nerve growth factor in the blood serum].
    Shcherbakova IV; Efanova NN; Orlova VA; Kliushnik TP; Voskresenskaia NI; Gubskiĭ AV; Kupriianov DA; Ganisheva TK; Anisimov NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):44-6. PubMed ID: 19365391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of immunological and clinical parameters in the treatment of childhood schizophrenia].
    Kliushnik TP; Kalinina MA; Sarmanova ZV; Otman IN; Kozlovskaia GV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):46-9. PubMed ID: 19672227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the level of autoantibodies to the nerve growth factor in the blood serum of schizophrenia patients].
    Kliushnik TP; Danilovskaia EV; Vatolkina OE; Turkova IL; Tsutsul'kovskaia MIa; Orlova VA; Kaleda VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(3):32-4. PubMed ID: 9575628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology.
    Shcherbakova IV; Siryachenko TM; Mazaeva NA; Kaleda VG; Krasnolobova SA; Klyushnik TP
    World J Biol Psychiatry; 2004 Jul; 5(3):143-8. PubMed ID: 15346538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group].
    Kozlovskaia GV; Kliushnik TP; Goriunova AV; Turkova IL; Kalinina MA; Sergienko NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(3):50-2. PubMed ID: 10758649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An elevation in the level of autoantibodies to nerve-growth factor in the blood serum of schizophrenic children].
    Bashina VM; Kozlova IA; Kliushnik TP; Simashkova NV; Danilovskaia EV; Gorbachevskaia NL; Turkova IL; Iakupova LP; Grachev VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(1):47-51. PubMed ID: 9163249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between the level of autoantibodies to nerve growth factor and clinical features of schizophrenia in children].
    Kliushnik TP; Turkova IL; Danilovskaia EV; Kozlova IA; Bashina VM; Simashkova NV; Vabishchevich NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(1):49-51. PubMed ID: 11530461
    [No Abstract]   [Full Text] [Related]  

  • 8. [A state of innate and adaptive immunity in children with schizophrenia and in the high-risk group for the disease].
    Shcherbakova IV; Kozlovskaia GV; Kalinina MA; Kliushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(11):45-9. PubMed ID: 16329635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-directed autoantibodies levels in the serum of Rett syndrome patients.
    Klushnik TP; Gratchev VV; Belichenko PV
    Brain Dev; 2001 Dec; 23 Suppl 1():S113-7. PubMed ID: 11738855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia.
    Xiong P; Zeng Y; Wan J; Xiaohan DH; Tan D; Lu J; Xu F; Li HY; Zhu Z; Ma M
    Psychiatry Res; 2011 Aug; 189(1):72-6. PubMed ID: 21277636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nerve growth factor auto-antibodies in the sera of mothers of schizophrenic children and children from high risk group].
    Zakharenko OM; Kliushnik TP; Kozlova IA; Kozlovskaia GV; Danilovskaia EV; Bashina VM; Simashkova VM; Goriunova AV; Kalinina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(3):44-6. PubMed ID: 10205843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.
    Ajami A; Hosseini SH; Taghipour M; Khalilian A
    Scand J Immunol; 2014 Jul; 80(1):36-42. PubMed ID: 24498860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia.
    Xiong P; Zeng Y; Zhu Z; Tan D; Xu F; Lu J; Wan J; Ma M
    Schizophr Res; 2010 Jun; 119(1-3):34-9. PubMed ID: 20303241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the serum levels of autoantibody to nerve growth factor in patients with schizophrenia.
    Klyushnik TP; Danilovskaya EV; Vatolkina OE; Turkova IL; Tsutsul'kovskaya MYa ; Orlova VA; Kaleda VG
    Neurosci Behav Physiol; 1999; 29(3):355-7. PubMed ID: 10493550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke].
    Kamchatov PR; Ruleva NIu; Dugin SF; Buriachkovskaia LI; Chugunov AV; Mikhaĭlova NA; Basse DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):69-72. PubMed ID: 19894304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MRI study of structural variations in schizophrenia using deformation field morphometry.
    Yoon U; Lee JM; Kwon JS; Kim HP; Shin YW; Ha TH; Kim IY; Chang KH; Kim SI
    Psychiatry Res; 2006 Mar; 146(2):171-7. PubMed ID: 16510267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential relationship of frontal pole and whole brain volumetric measures with age in neuroleptic-naïve schizophrenia and healthy subjects.
    John JP; Burgess PW; Yashavantha BS; Shakeel MK; Halahalli HN; Jain S
    Schizophr Res; 2009 Apr; 109(1-3):148-58. PubMed ID: 19185466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.